Douglas Levinson

Stanford University, Palo Alto, CA 
"Douglas Levinson"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu D, Meyer D, Fennessy B, et al. (2023) Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations. Nature Genetics. 55: 369-376
Trubetskoy V, Pardiñas AF, Qi T, et al. (2022) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature
Zhu X, Zhou B, Pattni R, et al. (2021) Machine learning reveals bilateral distribution of somatic L1 insertions in human neurons and glia. Nature Neuroscience
Cai N, Revez JA, Adams MJ, et al. (2020) Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nature Genetics
Ho KWD, Han S, Nielsen JV, et al. (2018) Genome-wide association study of seasonal affective disorder. Translational Psychiatry. 8: 190
Duncan LE, Shen H, Ballon JS, et al. (2017) Genetic Correlation Profile of Schizophrenia Mirrors Epidemiological Results and Suggests Link Between Polygenic and Rare Variant (22q11.2) Cases of Schizophrenia. Schizophrenia Bulletin
Van der Auwera S, Peyrot WJ, Milaneschi Y, et al. (2017) Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Levinson D, Potash J, Mostafavi S, et al. (2017) Brief Assessment Of Major Depression For Genetic Studies: Validation Of Cidi-Sf Screening With Scid Interviews European Neuropsychopharmacology. 27
Gill M, Corvin A, Daly M, et al. (2017) PGC3 AIM 6 - Large Scale Wgs of Multiply Affected Pedigrees European Neuropsychopharmacology. 27
Sullivan P, Smoller J, Levinson D. (2017) The Science of The Psychiatric Genomics Consortium (Part 2) European Neuropsychopharmacology. 27
See more...